These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20227232)

  • 1. Establishing axillary Sentinel Lymph Node Biopsy (SLNB) for early breast cancer in the United Kingdom: a survey of the national training program.
    Keshtgar M; Aresti N; Macneil F
    Eur J Surg Oncol; 2010 Apr; 36(4):393-8. PubMed ID: 20227232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a national training programme in sentinel lymph node biopsy for breast cancer.
    Mansel RE; MacNeill F; Horgan K; Goyal A; Britten A; Townson J; Clarke D; Newcombe RG; Keshtgar M; ; ; Kissin M; Layer G; Hilson A; Ell P; Wishart G; Brown D; West N
    Br J Surg; 2013 Apr; 100(5):654-61. PubMed ID: 23389843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense.
    Davis KG; Schriver JP; Waddell B
    Am J Surg; 2002 Aug; 184(2):94-6. PubMed ID: 12169350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
    Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
    Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
    Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study.
    Verheuvel NC; Voogd AC; Tjan-Heijnen VCG; Roumen RMH
    Ann Surg Oncol; 2017 Aug; 24(8):2155-2160. PubMed ID: 28258414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology.
    Luini A; Galimberti V; Gatti G; Arnone P; Vento AR; Trifirò G; Viale G; Rotmensz N; Fernandez JR; Gilardi D; Paganelli G
    Breast Cancer Res Treat; 2005 Jan; 89(2):159-63. PubMed ID: 15692758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky.
    Conn CA; McMasters KM; Edwards MJ; Martin RC
    Breast J; 2005; 11(4):231-5. PubMed ID: 15982387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.
    Caudle AS; Bedrosian I; Milton DR; DeSnyder SM; Kuerer HM; Hunt KK; Mittendorf EA
    Ann Surg Oncol; 2017 Oct; 24(10):2925-2934. PubMed ID: 28766207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
    Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.